Shareholders Approve US Redomiciliation and NYSE Listing Plan
NVA has more than doubled off its 52-week low of $1.68.
Summary
Nova Minerals shareholders and warrantholders have overwhelmingly approved the schemes of arrangement to redomicile the company to the US and list on the NYSE, marking a critical step in its corporate restructuring.
Key Events · M&A and Partnerships · NVA
-
Shareholder Approval Secured
Shareholders voted 98.88% in favor of the Share Scheme, approving the proposed redomiciliation.
-
Warrantholder Approval Achieved
Listed Warrantholders voted 99.89% in favor of the Warrant Scheme, supporting the corporate restructuring.
-
Critical Step for US Redomiciliation
These approvals are essential for the company's plan to establish a new US holding entity and list on the NYSE, delisting from ASX and NASDAQ.
-
Upcoming Implementation Timeline
The schemes are subject to a Second Court Hearing on June 2, 2026, with implementation and NYSE admission expected by June 16, 2026.
Analysis · NVA · Energy & Transportation
Nova Minerals' shareholders and warrantholders have overwhelmingly approved the schemes of arrangement to redomicile the company to the US and list on the NYSE. This successful vote is a critical milestone for the company's strategic shift to enhance access to US capital markets and potentially increase investor visibility. The schemes are now subject to final court approval on June 2, 2026, with implementation expected by June 16, 2026, leading to a new listing on the NYSE.
How filings like this one have moved
In the 30 days to Sep 13, 2026, 35.3% of the 1324 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.36%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NVA was trading at $6.48 on NASDAQ in the Energy & Transportation sector, with a market capitalization of approximately $248.4M. The 52-week trading range was $1.68 to $16.28. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.